Activation of N-methyl-D-aspartate receptors (NMDARs) mediates changes in the phosphorylation status of the glutamate receptors themselves. Previous studies have indicated that during synaptic activity, tyrosine kinases (Src and Fyn) or phosphatases (PTPα and STEP) are involved in regulating the phosphorylation of NMDARs. In this study, we used immunoblotting to investigate the role of an NMDAR subpopulation on the phosphorylation level of the GluN2B subunit at the Y1336 and Y1472 sites in rat brain slices after NMDA treatment. We found that NMDA stimulation dramatically decreased the phosphorylation level of GluN2B at Y1472 in a dose-and time-dependent manner, but not at Y1336. Extrasynaptic NMDAR activation did not reduce the phosphorylation of GluN2B at Y1472. In addition, ifenprodil, a selective antagonist of GluN2B-containing NMDARs, did not abolish the decreased phosphorylation of GluN2B at Y1472 triggered by NMDA. These results suggest that the activation of synaptic GluN2A-containing NMDARs is required for the decreased phosphorylation of GluN2B at Y1472 that is induced by NMDA treatment in rat brain slices.
INTRODUCTION
Glutamate, the major excitatory neurotransmitter in the brain, plays a vital role in many functions in the nervous system by activating ionotropic as well as metabotropic glutamate receptors. Ionotropic receptors include those activated by α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), N-methyl-D-aspartate (NMDA) and kainate. The NMDAR is a heteromeric molecule containing four subunits, two fundamental GluN1 subunits that are essential, and two GluN2 subunits (GluN2A and GluN2B). Recent evidence further revealed GluN3 subunits (GluN3A and GluN3B) that also modulate the properties of the NMDAR [1] [2] [3] . Dysfunction of NMDARs occurs in many neurological diseases, including stroke, epilepsy, Alzheimer's disease, and Parkinson's disease [4, 5] .
Phosphorylation of NMDARs is one of the most important mechanisms of their regulation [5] . Previous electrophysiological studies have shown that NMDAR currents in neurons are governed by a balance between tyrosine phosphorylation and dephosphorylation [6, 7] .
Accumulating evidence also shows that tyrosine phosphorylation of GluN2B plays a critical role in modulating NMDAR functions [5] . Three major tyrosine residues have been identified in the GluN2B C-terminus, designated Y1252, Y1336 and Y1472 [5] . In particular, Y1472 is thought to be the major tyrosine phosphorylation site enzymatically catalyzed by Fyn and Src kinases [8, 9] , and is directly involved in synaptic plasticity. For instance, phosphorylation at Y1472 is increased during long-term potentiation (LTP) and decreased during long-term depression (LTD) [10] , as well as preventing the endocytosis of GluN2B by disrupting AP-2 binding to GluN2B [8] . In addition, the fear learning and memory of Y1472F knock-in mice (a knock-in mutation of the Tyr1472 site to phenylalanine) is impaired [11] , providing the first evidence for the physiological function of Y1472 in vivo. Very recently, Harrington et al. found that phosphorylation of GluN2B at Y1472 is necessary for the formation of taste memory in rats [12] . In addition, some studies have also shown that phosphorylation at Y1336 is involved in calpain-mediated cleavage of GluN2B [13] . All this evidence strongly suggests that tyrosine phosphorylation of GluN2B is vital for the processes that underlie physiological and pathological plasticity in the brain.
Although previous studies have revealed the phosphorylation regulation of AMPARs by NMDA treatment [14] , little is known about tyrosine phosphorylation changes in GluN2B under NMDA stimulation. Furthermore, which NMDAR subtype is involved remains unknown.
Thus, the present study was designed to investigate the phosphorylation changes of GluN2B at both Y1472 and Y1336 in acute rat brain slices after NMDA stimulation.
MATERIALS AND METHODS

Antibodies and Reagents
The secondary antibodies, goat anti-mouse IgG Dylight TM 680 and goat anti-rabbit IgG Dylight TM 800, were from Thermo Electron Corp. (San Jose, CA). GluN2B mouse monoclonal antibody was made in our lab as described previously [15, 16] . Phospho-GluN2B antibodies (pY1472 and pY1336) were from Invitrogen (Carlsbad, CA).
All other reagents were from Sigma (St. Louis, MO) unless otherwise noted.
Preparation of Acute Hippocampal Slice
Male Sprague-Dawley rats (4-6 weeks) were used in this study. All animal experiments were performed in accordance with the ethical guidelines of the National
Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Zhejiang University Animal Experimentation Committee. Preparation of transverse hippocampal slices was performed as described previously [17] . 
Treatment of Acute Hippocampal Slices
The hippocampal slices were transferred to 26°C
oxygenated ACSF with (in μmol/L) 1 TTX, 40 CNQX, 100
APV, and 5 nimodipine for 3 h [18] prior to NMDA treatment as below. Extrasynaptic NMDARs were selectively activated according to the procedures described previously [14, 18] . 
SDS-PAGE and Semi-Quantitative Western Blotting Analysis
Sample preparation was performed as described previously [19] . Briefly, slices were homogenized in ice-cold homogenization buffer (10 mmol/L Tris-HCl buffer, pH 7.4, containing in mmol/L 320 sucrose, 1 Na 3 VO 4 , 5 NaF, 1 
Data Analysis
Data are presented as mean ± SEM from at least three independent experiments. Statistical analysis was performed with Graphpad Prism 5.0 software. Statistical differences were determined by one-way ANOVA. P <0.05 was considered to be statistically signifi cant.
RESULTS
NMDAR Activation Regulates Phosphorylation of GluN2B at Y1472 but not Y1336
To evaluate the effects of NMDA activation on the tyrosine phosphorylation of GluN2B subunit residues Y1336 and Y1472, a series of concentrations of NMDA (from 10 to 300 μmol/L) was applied to the slices. Stimulation of slices with 10 μmol/L NMDA induced minor phosphorylation changes at Y1472 (Fig. 1A) . However, 20 to 300 μmol/L NMDA significantly decreased the phosphorylation at Y1472 (Fig. 1A) . Conversely, NMDAR activation resulted in no signifi cant changes of GluN2B phosphorylation at Y1336 at all NMDA concentrations used (Fig. 1B) . Thus, our results suggested that bath application of NMDA that selectively activates NMDARs, reduces the phosphorylation level of GluN2B at Y1472, but not at Y1336.
NMDA Stimulation Induces a Persistent Decrease of
GluN2B Phosphorylation at Y1472
To characterize the time-window of phosphorylation changes In order to verify the contribution of one subpopulation of NMDARs, we used the extrasynaptic activation protocol as described previously [14] . Our data clearly revealed that the selective extrasynaptic activation of NMDARs failed to induce any detectable phosphorylation changes compared to that of the untreated control group (Fig. 3) , suggesting that synaptic NMDAR activation is responsible for the changes of GluN2B phosphorylation at Y1472.
Extrasynaptic Activation of NMDARs Fails to Elicit Detectable Changes of GluN2B Phosphorylation at
Y1472
It is of interest to determine whether the changes in GluN2B phosphorylation at Y1472 are due to activation of synaptic or extrasynaptic NMDARs. A growing body of evidence shows that activation of synaptic or extrasynaptic NMDARs leads to distinct or even opposite consequences via activation of different downstream signaling pathways [20] .
GluN2A Subunit-containing NMDARs Predominate in the Down-regulation of GluN2B Phosphorylation at
Y1472
Considerable evidence shows that, in developmentally mature synapses, GluN2A-containing NMDARs occur in synaptic locations, while those containing GluN2B mainly occupy extrasynaptic sites [21, 22] . Based on the results shown in Fig. 3 , we speculated that GluN2A-containing NMDARs play a dominant role in mediating the decreased GluN2B phosphorylation at Y1472. Indeed, selective blockade of GluN2B-containing NMDARs by 10 μmol/L ifenprodil failed to inhibit the phosphorylation changes induced by NMDA (Fig. 4) . Conversely, the NMDA-induced reduction of phosphorylation at Y1472 was abolished by the NMDAR antagonist MK801 that blocked the open NMDARs that In the present study, our data fi rst showed that NMDAR activation decreased tyrosine phosphorylation of GluN2B at Y1472, but not at Y1336, suggesting that NMDAR activation differentially regulates different tyrosine sites of the GluN2B subunit.
Previous studies have indicated that 20 μmol/L
NMDA treatment induces chemical LTD [27] , but a very high concentration of NMDA, such as 100 or 300 μmol/L, induces neuron death [28] . In our study, 10 μmol/L NMDA did not induce any detectable changes in GluN2B Y1472, but concentrations from 20 to 300 μmol/L decreased it in a time-dependent pattern. These data implied that both chemical LTD induction and NMDAR-mediated excitotoxicity result in a decrease in NMDARs on the cell surface, possibly by promoting the endocytosis of GluN2B-containing NMDARs.
NMDARs are located in neuronal cell membranes at synaptic and extrasynaptic sites, where they are believed to mediate distinct physiological and pathological processes [29, 30] . To further identify whether synaptic or extrasynaptic NMDARs are responsible for regulating the tyrosine phosphorylation of GluN2B at Y1472, we selectively blocked the synaptic NMDARs in brain slices.
Our data showed that synaptic NMDAR inhibition abolished the reduction in GluN2B phosphorylation at Y1472 induced by NMDA. Interestingly, a recent study indicated that GluN2B phosphorylation at Y1472 is associated with an enrichment of synaptic NMDARs [31] , suggesting that these receptors control the synaptic pool of NMDARs by regulating the tyrosine phosphorylation of GluN2B at Y1472.
It is also well known that GluN2A and GluN2B are the prevalent subunits in NMDARs in the forebrain [32] and they 
DISCUSSION
Many studies have focused on the regulation of phosphorylation of AMPARs by NMDAR activation. The
GluN2 subunits of NMDAR are differentially tyrosinephosphorylated, which is important for regulating NMDAR function [23] . Previous studies have indicated that many factors such as brain-derived neurotrophic factor, dopamine receptors, and Src family kinases [24] [25] [26] regulate the tyrosine phosphorylation of GluN2A and GluN2B subunits. However, the self-contribution of NMDAR activation to GluN2 tyrosine occur at both synaptic and extrasynaptic sites. In adulthood,
GluN2A is dominant in the synapse, while the extrasynaptic region contains more GluN2B [21, 22] . Here, by applying the GluN2B-specific inhibitor ifenprodil, we demonstrated that GluN2A-containing NMDARs were responsible for the reduction of phosphorylation of GluN2B at Y1472
induced by NMDA in brain slices. It is known that GluN2B
is dominant in early development, while GluN2A expression gradually increases during brain development. Until now, accumulating evidence suggests that expression of both GluN2A and GluN2B subunits in rats is stable four weeks after birth [33, 34] . Therefore, the expression of the GluN2A and GluN2B subunits was stable in our model, which implied that our results represent a general mechanism in adult rats.
Previous studies indicated that GluN2A-containing NMDARs are associated with neuroprotection, while GluN2B-containing NMDARs are involved in cell death [35] .
In other words, synaptic NMDARs play a neuroprotective role [36] , while extrasynaptic NMDARs are conducive to neuronal excitotoxicity [36] . Our results showed that a high concentration of NMDA (100 or 300 μmol/L) decreased tyrosine phosphorylation of GluN2B at Y1472. According to these data, it is possible that synaptic GluN2A-containing NMDARs protect neurons from NMDA-induced excitotoxicity by reducing the number of GluN2B-containing NMDARs on the cell surface. It will be interesting to uncover how synaptic GluN2A-containing NMDAR activation regulates the tyrosine phosphorylation of GluN2B at Y1472.
